The day began with a coordinated Awareness Walk, bringing together staff, healthcare professionals, partners, volunteers, and community members in a visible show of commitment to malaria prevention and control. Despite significant global progress, malaria remains one of the most pressing public health challenges in sub-Saharan Africa, with Nigeria bearing the heaviest global burden. According to the World Health Organization, Nigeria accounts for approximately 27% of global malaria cases and nearly one in three malaria-related deaths. With children under five being disproportionately affected, Emzor has stated that access to effective, child-friendly treatment is not just a medical necessity, but a moral imperative.

Despite early morning rainfall, participation remained undaunted. The persistence of the walk under challenging weather conditions became a powerful symbol of resilience and urgency. This reinforces the message that malaria does not pause for convenience, and neither should the response to it. Throughout the walk, key messages on early diagnosis, effective treatment, and preventive practices were actively communicated, extending the reach of malaria awareness beyond traditional channels and into the public space.

As the rain subsided, activities transitioned seamlessly to a medical outreach held at Emzor Pharmacy and Stores. The outreach was carefully structured to ensure both efficiency and participant comfort. Canopies were installed to create a secure and organized environment where attendees could be seated and attended to systematically. This setup enabled a smooth flow of participants while maintaining a professional standard of care delivery.

The medical outreach provided free access to essential health services, including malaria testing, Hepatitis B screening, blood pressure measurement, and general medical consultations. Each service point was managed by trained healthcare personnel, ensuring accuracy, professionalism, and patient-centered care. The initiative addressed a critical gap in access to basic health screenings, particularly for individuals who may not routinely engage with formal healthcare systems.

A notable outcome of the outreach was the level of first-time engagement. Many participants underwent malaria testing for the first time, gaining immediate insight into their health status and the importance of early detection. Others were able to assess previously unknown risk factors, such as elevated blood pressure levels. This shows the broader value of integrated health screenings. Beyond diagnosis, the consultations also provided an opportunity for health education, thereby equipping individuals with practical knowledge on prevention, treatment adherence, and when to seek medical care.

In parallel with service delivery, Emzor reinforced its strategic positioning through the release of its World Malaria Day press statement, deliberately aligning advocacy with on-ground impact. The statement reaffirmed the company’s commitment to advancing malaria control through sustained innovation, expanded access to quality medicines, and stronger collaboration across the healthcare ecosystem. It emphasized that even though progress has been made, malaria elimination requires consistent, coordinated, and scalable interventions supported by both public and private sector stakeholders.

Importantly, Emzor called for increased investment in local pharmaceutical manufacturing, particularly in Active Pharmaceutical Ingredients (APIs), as a critical step toward ensuring medicine security and reducing reliance on imports. The statement also highlighted the urgent need to prioritize vulnerable populations by expanding access to child-friendly treatments and preventive therapies for pregnant women. This includes the continued availability of dispersible antimalarial formulations designed to improve ease of administration, dosing accuracy, and treatment adherence among young children, as well as preventive therapies that support maternal health during pregnancy. 

The integration of these elements from public awareness to clinical service delivery demonstrates a comprehensive model for tackling malaria. Rather than operating in silos, Emzor’s approach aligns field-level engagement with broader health system priorities, ensuring that impact is both immediate and sustainable. 

As the global health community continues to push toward malaria elimination targets, the pathway has been defined. The solutions are available.

Now we can. Now we must.

The post first appeared on Emzor.

The post appeared first on Emzor.

Hepatitis, a disease often overshadowed by more high-profile illnesses, silently wreaks havoc on millions of lives worldwide. This condition, which involves inflammation of the liver, can lead to severe health complications and even death if left untreated. Despite its prevalence, awareness and understanding of hepatitis remain alarmingly low. 

Understanding Hepatitis: Types and Transmission

The most common types are hepatitis A, B, C, D, and E, each caused by a different virus and differing in transmission and severity. Hepatitis is caused by viruses, alcohol use, certain medications, and other medical conditions. 

Hepatitis A and E

Hepatitis A and E are typically transmitted through the ingestion of contaminated food or water. These forms of hepatitis are more common in regions with poor sanitation and can cause acute, but usually not chronic, liver infection. Symptoms include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, joint pain, and jaundice.

Hepatitis B and C

Hepatitis B and C are primarily spread through contact with infectious body fluids, such as blood, semen, and vaginal fluids. This can occur through unprotected sex, sharing needles, and from mother to child during childbirth. Both types can lead to chronic liver disease, cirrhosis, and liver cancer. Hepatitis B has a vaccine, while hepatitis C does not, making awareness and prevention extremely important.

Hepatitis D

Hepatitis D is a less common form that only occurs in conjunction with hepatitis B, as it requires the hepatitis B virus to replicate. It is transmitted through contact with infected blood and body fluids. 

The Silent Nature of Hepatitis

One of the most insidious aspects of hepatitis is its often silent progression. Many people infected with hepatitis B or C can remain asymptomatic for years or even decades, unknowingly transmitting the virus to others and suffering liver damage. By the time symptoms appear, significant liver damage may have already occurred. 

Early symptoms can be nonspecific, such as fatigue, mild fever, and loss of appetite. As the disease progresses, more severe symptoms like jaundice, abdominal pain, and dark urine may develop. Chronic hepatitis can lead to severe liver damage, cirrhosis, and liver cancer, which are often fatal if not managed properly.

Early Detection and Treatment

Early detection of hepatitis can significantly improve outcomes. Screening for hepatitis B and C is recommended for individuals at high risk, including those with a history of intravenous drug use, those who have received blood transfusions before 1992, and those born to infected mothers. 

Importance of Vaccination and Early Detection

Vaccination

Vaccination is a powerful tool in the fight against hepatitis, particularly for hepatitis A and B. The hepatitis B vaccine is part of routine immunizations for children in many countries and is also recommended for adults at higher risk..

Emzor’s Commitment to Combating Hepatitis

At Emzor Pharmaceuticals, we are dedicated to raising awareness about hepatitis and promoting preventive measures such as vaccination and early screening. We believe that through education, early detection, and effective treatment, we can significantly reduce the burden of this silent epidemic.

We value your health above all; that is why we offer a specialized vaccination program for you. If you would like your company or a group of people in your circle to get vaccinated, do well to reach out to us. 

Hepatitis continues to be a major global health concern, claiming lives in silence because of a lack of early detection and awareness. Emzor Pharmaceuticals is dedicated to taking a leading position in this battle and providing encouragement and support to hepatitis sufferers. 

Frequently Asked Questions (FAQs)

 How can I schedule a vaccination session for my company or group?

Scheduling a vaccination session with Emzor is simple. Contact our customer service team through our website or call our dedicated hotline. Provide details about your company or group size, preferred dates, and any specific vaccine requirements, and we’ll take care of the rest.

Are there any other ways of contracting hepatitis besides the methods mentioned here?

Yes, hepatitis can also be contracted through using unsterilized medical or dental equipment, sharing personal items like razors or toothbrushes with an infected person, and receiving tattoos or piercings with non-sterile instruments.

The post Hepatitis: The Silent Epidemic Destroying Lives first appeared on Emzor.

The post Hepatitis: The Silent Epidemic Destroying Lives appeared first on Emzor.